The University of Queensland

C3/C5 Convertase Inhibitors as a new class of anti-inflammatory drugs (2004–2006)

Grant type:

NHMRC Project Grant

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

Funded by:

National Health and Medical Research Council